Skip to content

Kyphotic Measure Using Distance From the Wall

Kyphotic Measure Using Distance From the Wall: Reliability, Validity and Distance From the Wall to Indicate Risk for Spinal Fracture

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02914041
Enrollment
96
Registered
2016-09-26
Start date
2016-02-29
Completion date
2017-08-31
Last updated
2017-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kyphosis

Keywords

Kyphosis, Kyphosis wall distance, elderly

Brief summary

Are the KypDisT and conventional C7WD are practical, valid, reliable, and effectiveness of the tools to discriminate the functional ability impairments relating to kyphosis when compare with gold standard (Cobb's method), and compare among physical therapy, VHS and caregiver?

Detailed description

1. To further develop an innovation to measure kyphosis using distance from the wall, a Kyphosis wall distance tool (KypDisT). 2. investigate validity of the measurements in terms of 2.1 Concurrent validity of conventional C7WD and KypDisT as compared to a gold standard (Cobb's method). 2.2 Discriminative ability of conventional C7WD and KypDisT on functional abilities in elderly with different severity of kyphosis. 3. To investigate the reliability of the measurements in terms of 3.1 Test-retest reliability of conventional C7WD and KypDisT. 3.2 Reliability of conventional C7WD and KypDisT comparing among physical therapy, VHS and caregiver. 4. To explore the distance to indicate risk of spinal fracture to indicate a risk of spinal fracture.

Interventions

None listed

Sponsors

Khon Kaen University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Community-dwelling elderly with different degrees of kyphosis, * Aged at least 60 years * Body mass index between 18.5-29.9 kg/m2 * OWD \>0 cm.

Exclusion criteria

* Present signs and symptoms that may affect participation in the study, i.e. unstable medical condition, pain or inflammation in the joints of the lower extremity (pain scale \> 5), having sequelae of neurological deficits * Unable to understand and follow a simple command used in the study.

Design outcomes

Primary

MeasureTime frameDescription
KMD7 daysKyphosis assessments using distance from the wall

Secondary

MeasureTime frameDescription
10MWT1 daywalking speed
FTSST1 dayLower limb muscle strength
TUGT1 dayBalance control
6MinWT1 dayWalking endurance

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026